Detalles de la búsqueda
1.
PI3Kδ inhibitor, GS-1101 (CAL-101), attenuates pathway signaling, induces apoptosis, and overcomes signals from the microenvironment in cellular models of Hodgkin lymphoma.
Blood
; 119(8): 1897-900, 2012 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-22210877
2.
The phosphoinositide 3'-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia.
Blood
; 118(13): 3603-12, 2011 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-21803855
3.
CAL-101, a p110delta selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability.
Blood
; 117(2): 591-4, 2011 Jan 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-20959606
4.
PI3Kδ inhibitor idelalisib in combination with BTK inhibitor ONO/GS-4059 in diffuse large B cell lymphoma with acquired resistance to PI3Kδ and BTK inhibitors.
PLoS One
; 12(2): e0171221, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28178345
5.
Ala657 and conserved active site residues promote fibroblast activation protein endopeptidase activity via distinct mechanisms of transition state stabilization.
Biochemistry
; 46(15): 4598-605, 2007 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-17381073
Resultados
1 -
5
de 5
1
Próxima >
>>